Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Sulfamerazine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Sulfamerazine | hsa00190 | Oxidative phosphorylation | 8.71E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Sulfamerazine | hsa00220 | Arginine biosynthesis | 1.21E-02 | 1 | P15104 | GLUL | More | | Sulfamerazine | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Sulfamerazine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Sulfamerazine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Sulfamerazine | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Sulfamerazine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.84E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Sulfamerazine | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Sulfamerazine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Sulfamerazine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Sulfamerazine | hsa01230 | Biosynthesis of amino acids | 5.53E-03 | 2 | P15104, P37837 | GLUL, TALDO1 | More | | Sulfamerazine | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Sulfamerazine | hsa03015 | mRNA surveillance pathway | 4.42E-02 | 4 | O60942, O43148, P52298, Q53GS7 | RNGTT, RNMT, NCBP2, GLE1 | More | | Sulfamerazine | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Sulfamerazine | hsa03040 | Spliceosome | 1.93E-03 | 9 | Q14562, O60508, P17844, P08579, P51991, P61978, Q01130, P11142, O43447 | DHX8, CDC40, DDX5, SNRPB2, HNRPA3, HNRPK, SFRS2, HSPA8, PPIH | More | | Sulfamerazine | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Sulfamerazine | hsa04014 | Ras signaling pathway | 7.30E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04015 | Rap1 signaling pathway | 6.14E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04024 | cAMP signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04064 | NF-kappa B signaling pathway | 3.49E-03 | 10 | P10415, Q13489, P01584, P29965, Q9UDY8, Q8WV28, Q13315, P63279, Q8NHW4, Q9NQC7 | BCL2, BIRC3, IL1B, CD40LG, MALT1, BLNK, ATM, UBE2I, CCL4L2, CYLD | More | | Sulfamerazine | hsa04070 | Phosphatidylinositol signaling system | 3.47E-02 | 4 | P0DP23, Q14643, P23743, P17252 | CALM1, ITPR1, DGKA, PRKCA | More | | Sulfamerazine | hsa04071 | Sphingolipid signaling pathway | 2.37E-03 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Sulfamerazine | hsa04140 | Autophagy - animal | 3.72E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Sulfamerazine | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Sulfamerazine | hsa04142 | Lysosome | 2.45E-03 | 9 | Q99437, P25774, P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | ATP6V0B, CTSS, HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Sulfamerazine | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Sulfamerazine | hsa04145 | Phagosome | 8.64E-05 | 10 | P63261, Q15080, P14598, Q13509, P68371, Q13488, Q99437, O60603, P13765, P25774 | ACTG1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, ATP6V0B, TLR2, HLA-DOB, CTSS | More | | Sulfamerazine | hsa04151 | PI3K-Akt signaling pathway | 1.13E-03 | 16 | P62753, P25116, P27348, P49767, Q13362, P07900, P62873, P16144, P22105, O60603, P01568, Q99941, P18848, P10415, P17252, O00141 | RPS6, F2R, YWHAQ, VEGFC, PPP2R5C, HSP90AA1, GNB1, ITGB4, TNXB, TLR2, IFNA21, CREBL1, ATF4, BCL2, PRKCA, SGK | More | | Sulfamerazine | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Sulfamerazine | hsa04213 | Longevity regulating pathway - multiple species | 2.82E-02 | 3 | Q08828, P51828, P0DMV8 | ADCY1, ADCY7, HSPA1A | More | | Sulfamerazine | hsa04217 | Necroptosis | 1.70E-04 | 9 | P01568, Q13489, Q13546, P42224, P07384, Q6FI13, P10415, O43633, Q08752 | IFNA21, BIRC3, RIPK1, STAT1, CAPN1, H2AC18; H2AC19, BCL2, CHMP2A, PPID | More | | Sulfamerazine | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.02E-04 | 10 | P09493, P51828, P31751, Q99941, P18848, Q13362, P0DP23, Q13557, P17252, P10415 | TPM1, ADCY7, AKT2, CREBL1, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2 | More | | Sulfamerazine | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Sulfamerazine | hsa04370 | VEGF signaling pathway | 3.60E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04371 | Apelin signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04380 | Osteoclast differentiation | 2.11E-03 | 2 | Q9NQC7, P31751 | CYLD, AKT2 | More | | Sulfamerazine | hsa04510 | Focal adhesion | 4.64E-02 | 6 | O75369, Q15942, Q13489, P10415, P49767, P63261 | FLNB, ZYX, BIRC3, BCL2, VEGFC, ACTG1 | More | | Sulfamerazine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Sulfamerazine | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Sulfamerazine | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Sulfamerazine | hsa04612 | Antigen processing and presentation | 2.84E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Sulfamerazine | hsa04613 | Neutrophil extracellular trap formation | 6.21E-04 | 17 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Sulfamerazine | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | | Sulfamerazine | hsa04623 | Cytosolic DNA-sensing pathway | 6.24E-04 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Sulfamerazine | hsa04625 | C-type lectin receptor signaling pathway | 1.38E-05 | 3 | Q9NQC7, P31751, P0DP23 | CYLD, AKT2, CALM1 | More | | Sulfamerazine | hsa04640 | Hematopoietic cell lineage | 3.58E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Sulfamerazine | hsa04658 | Th1 and Th2 cell differentiation | 1.48E-02 | 7 | Q04759, P20963, P09693, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, STAT4, GATA3, TBX21, HLA-DOB | More | | Sulfamerazine | hsa04660 | T cell receptor signaling pathway | 3.19E-03 | 10 | P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191 | TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB | More | | Sulfamerazine | hsa04662 | B cell receptor signaling pathway | 1.60E-04 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Sulfamerazine | hsa04664 | Fc epsilon RI signaling pathway | 4.79E-03 | 4 | P31751, P42338, P07948, P09917 | AKT2, PIK3CB, LYN, ALOX5 | More | | Sulfamerazine | hsa04672 | Intestinal immune network for IgA production | 1.27E-04 | 4 | P29965, P10747, P13765, P13612 | CD40LG, CD28, HLA-DOB, ITGA4 | More | | Sulfamerazine | hsa04713 | Circadian entrainment | 2.60E-02 | 4 | P0DP23, P17252, P62873, Q14643 | CALM1, PRKCA, GNB1, ITPR1 | More | | Sulfamerazine | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Sulfamerazine | hsa04720 | Long-term potentiation | 3.89E-02 | 3 | P17252, P0DP23, Q14643 | PRKCA, CALM1, ITPR1 | More | | Sulfamerazine | hsa04722 | Neurotrophin signaling pathway | 2.83E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfamerazine | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Sulfamerazine | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Sulfamerazine | hsa04725 | Cholinergic synapse | 1.53E-04 | 10 | P51828, Q14643, P17252, P62873, P63218, P50151, P18848, Q13557, P42338, P10415 | ADCY7, ITPR1, PRKCA, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, BCL2 | More | | Sulfamerazine | hsa04727 | GABAergic synapse | 1.63E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Sulfamerazine | hsa04728 | Dopaminergic synapse | 4.05E-04 | 9 | Q14643, P17252, P62873, P31751, Q99941, P18848, Q13557, Q13362, P0DP23 | ITPR1, PRKCA, GNB1, AKT2, CREBL1, ATF4, CAMK2D, PPP2R5C, CALM1 | More | | Sulfamerazine | hsa04740 | Olfactory transduction | 2.41E-02 | 1 | P0DP23 | CALM1 | More | | Sulfamerazine | hsa04744 | Phototransduction | 1.74E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Sulfamerazine | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.01E-02 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | | Sulfamerazine | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Sulfamerazine | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Sulfamerazine | hsa04912 | GnRH signaling pathway | 3.41E-03 | 6 | P17252, P51828, P18848, Q13557, Q14643, P0DP23 | PRKCA, ADCY7, ATF4, CAMK2D, ITPR1, CALM1 | More | | Sulfamerazine | hsa04915 | Estrogen signaling pathway | 4.70E-05 | 10 | Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Sulfamerazine | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Sulfamerazine | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Sulfamerazine | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04922 | Glucagon signaling pathway | 2.33E-03 | 5 | Q12778, P31751, Q13370, P0DP23, Q14643 | FOXO1, AKT2, PDE3B, CALM1, ITPR1 | More | | Sulfamerazine | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04924 | Renin secretion | 2.43E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Sulfamerazine | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Sulfamerazine | hsa04926 | Relaxin signaling pathway | 5.00E-04 | 8 | P42338, P63218, P50151, Q99941, P18848, P49767, P51828, P49407 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7, ARRB1 | More | | Sulfamerazine | hsa04927 | Cortisol synthesis and secretion | 6.33E-04 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Sulfamerazine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Sulfamerazine | hsa04929 | GnRH secretion | 3.61E-03 | 3 | P42338, P31751, P49407 | PIK3CB, AKT2, ARRB1 | More | | Sulfamerazine | hsa04932 | Non-alcoholic fatty liver disease | 1.39E-02 | 6 | O43521, O75460, P01584, P13073, P12074, O95298 | BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | | Sulfamerazine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Sulfamerazine | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Sulfamerazine | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Sulfamerazine | hsa04940 | Type I diabetes mellitus | 3.64E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Sulfamerazine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Sulfamerazine | hsa04966 | Collecting duct acid secretion | 2.07E-03 | 3 | Q13488, P00918, Q9Y666 | TCIRG1, CA2, SLC12A7 | More | | Sulfamerazine | hsa04970 | Salivary secretion | 1.58E-03 | 7 | P07550, Q08828, P51828, P22694, Q14643, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, CALM1, CAMP | More | | Sulfamerazine | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Sulfamerazine | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Sulfamerazine | hsa05010 | Alzheimer disease | 7.72E-03 | 9 | Q16718, O14521, Q14643, Q00535, P0DP23, Q13509, P68371, P31751, Q08752 | NDUFA5, SDHD, ITPR1, CDK5, CALM1, TUBB3, TUBB2C, AKT2, PPID | More | | Sulfamerazine | hsa05012 | Parkinson disease | 2.25E-02 | 6 | Q16718, O14521, Q14643, P0DP23, Q13509, P68371 | NDUFA5, SDHD, ITPR1, CALM1, TUBB3, TUBB2C | More | | Sulfamerazine | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Sulfamerazine | hsa05020 | Prion disease | 1.15E-02 | 7 | Q16718, O14521, Q14643, Q13509, P68371, P14598, Q15080 | NDUFA5, SDHD, ITPR1, TUBB3, TUBB2C, NCF1, NCF4 | More | | Sulfamerazine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 5.01E-04 | 14 | Q14643, O15399, Q13509, P68371, P10415, Q16718, O14521, Q13561, P17252, P07384, Q00535, P04628, Q08752, P0DP23 | ITPR1, GRIN2D, TUBB3, TUBB2C, BCL2, NDUFA5, SDHD, DCTN2, PRKCA, CAPN1, CDK5, WNT1, PPID, CALM1 | More | | Sulfamerazine | hsa05030 | Cocaine addiction | 6.96E-03 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Sulfamerazine | hsa05031 | Amphetamine addiction | 9.24E-04 | 4 | P0DP23, Q13557, Q99941, P18848 | CALM1, CAMK2D, CREBL1, ATF4 | More | | Sulfamerazine | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Sulfamerazine | hsa05110 | Vibrio cholerae infection | 4.78E-02 | 1 | Q99437 | ATP6V0B | More | | Sulfamerazine | hsa05131 | Shigellosis | 2.27E-02 | 8 | P68431, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID | More | | Sulfamerazine | hsa05132 | Salmonella infection | 2.49E-04 | 11 | Q9UJU2, P63261, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371 | LEF1, ACTG1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Sulfamerazine | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Sulfamerazine | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | | Sulfamerazine | hsa05140 | Leishmaniasis | 2.17E-03 | 6 | P14598, P42224, P13765, O60603, P29350, Q15080 | NCF1, STAT1, HLA-DOB, TLR2, PTPN6, NCF4 | More | | Sulfamerazine | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Sulfamerazine | hsa05144 | Malaria | 6.79E-03 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Sulfamerazine | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Sulfamerazine | hsa05146 | Amoebiasis | 1.48E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Sulfamerazine | hsa05152 | Tuberculosis | 9.47E-05 | 11 | Q13488, Q99437, P0DP23, P42224, O60603, P31751, P10415, P13765, P25774, P01568, Q9UDY8 | TCIRG1, ATP6V0B, CALM1, STAT1, TLR2, AKT2, BCL2, HLA-DOB, CTSS, IFNA21, MALT1 | More | | Sulfamerazine | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Sulfamerazine | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Sulfamerazine | hsa05163 | Human cytomegalovirus infection | 6.29E-03 | 8 | P31751, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651 | AKT2, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA | More | | Sulfamerazine | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Sulfamerazine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.53E-03 | 7 | P01568, P31751, P42224, P62873, Q14643, P0DP23, Q9UJU2 | IFNA21, AKT2, STAT1, GNB1, ITPR1, CALM1, LEF1 | More | | Sulfamerazine | hsa05168 | Herpes simplex virus 1 infection | 1.17E-02 | 10 | Q9UKJ0, Q06124, P01568, Q01130, Q13489, Q13398, Q9NR11, Q03923, Q9UDV6, P10415 | PILRB, PTPN11, IFNA21, SFRS2, BIRC3, ZNF211, ZNF302, ZNF85, ZNF212, BCL2 | More | | Sulfamerazine | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Sulfamerazine | hsa05170 | Human immunodeficiency virus 1 infection | 2.70E-04 | 10 | P31751, P62873, P0DP23, P17252, Q14643, P01568, O60603, Q13315, P10415, Q9Y6Q5 | AKT2, GNB1, CALM1, PRKCA, ITPR1, IFNA21, TLR2, ATM, BCL2, AP1M2 | More | | Sulfamerazine | hsa05200 | Pathways in cancer | 8.38E-03 | 13 | P42224, Q9UJU2, P17252, P14923, P10415, Q13489, P49767, Q12778, P31751, P25116, P62873, P0DP23, P01568 | STAT1, LEF1, PRKCA, JUP, BCL2, BIRC3, VEGFC, FOXO1, AKT2, F2R, GNB1, CALM1, IFNA21 | More | | Sulfamerazine | hsa05202 | Transcriptional misregulation in cancer | 3.71E-02 | 11 | P14780, P27930, Q15744, Q16548, P35226, P05164, P12838, P08246, Q9C0K0, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, BMI1, MPO, DEFA4, ELA2, BCL11B, LYL1, GADD45A | More | | Sulfamerazine | hsa05203 | Viral carcinogenesis | 2.63E-03 | 7 | Q99941, P18848, P27348, Q15283, P61978, P62807, O60814 | CREBL1, ATF4, YWHAQ, RASA2, HNRPK, HIST1H2BC, H2BC12 | More | | Sulfamerazine | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Sulfamerazine | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05212 | Pancreatic cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05213 | Endometrial cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05214 | Glioma | 5.75E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Sulfamerazine | hsa05218 | Melanoma | 3.01E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05220 | Chronic myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05223 | Non-small cell lung cancer | 2.41E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05226 | Gastric cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfamerazine | hsa05310 | Asthma | 1.66E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Sulfamerazine | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Sulfamerazine | hsa05321 | Inflammatory bowel disease | 1.14E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Sulfamerazine | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Sulfamerazine | hsa05323 | Rheumatoid arthritis | 5.62E-04 | 6 | P01375, P13765, Q13488, P10747, P09341, O60603 | TNF, HLA-DOB, TCIRG1, CD28, CXCL1, TLR2 | More | | Sulfamerazine | hsa05330 | Allograft rejection | 1.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Sulfamerazine | hsa05332 | Graft-versus-host disease | 2.03E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Sulfamerazine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Sulfamerazine | hsa05415 | Diabetic cardiomyopathy | 3.55E-02 | 5 | P17252, P14598, Q15080, Q16718, O14521 | PRKCA, NCF1, NCF4, NDUFA5, SDHD | More | | Sulfamerazine | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Sulfamerazine | hsa05418 | Fluid shear stress and atherosclerosis | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | |